Cohort study on radioactive iodine-induced hypothyroidism: Implications for graves' ophthalmopathy and optimal timing for thyroid hormone assessment

Thyroid

Volumn 23, Issue 5, 2013, Pages 620-625

  Stan, Marius N ^a   Durski, Jolanta M ^a   Brito, Juan P ^a   Bhagra, Sumit ^a   Thapa, Prabin ^a   Bahn, Rebecca S ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE; THYROID HORMONE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; COHORT ANALYSIS; DRUG INDUCED DISEASE; ENDOCRINE OPHTHALMOPATHY; FEMALE; FOLLOW UP; FREE THYROXINE INDEX; HORMONE DETERMINATION; HUMAN; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PREVALENCE; PRIORITY JOURNAL; RADIOACTIVE IODINE INDUCED HYPOTHYROIDISM; RETROSPECTIVE STUDY; SMOKING;

ADULT; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GRAVES OPHTHALMOPATHY; HORMONE REPLACEMENT THERAPY; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; MINNESOTA; PREVALENCE; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; THYROID GLAND; THYROID HORMONES;

EID: 84880555944     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2012.0258     Document Type: Article

References (17)

1. Bartalena L, Marcocci C, Bogazzi F, Manetti L, Tanda ML, Dell'Unto E, Bruno-Bossio G, Nardi M, Bartolomei MP, Lepri A, Rossi G, Martino E, Pinchera A 1998 Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy. N Engl J Med 338:73-78.
2. Traisk F, Tallstedt L, Abraham-Nordling M, Andersson T, Berg G, Calissendorff J, Hallengren B, Hedner P, Lantz M, Nystrom E, Ponjavic V, Taube A, Torring O, Wallin G, Asman P, Lundell G 2009 Thyroid-associated ophthalmopathy after treatment for Graves' hyperthyroidism with antithyroid drugs or iodine-131. J Clin Endocrinol Metab 94:3700-3707.
3. Bartalena L, Marcocci C, Tanda ML, Manetti L, Dell'Unto E, Bartolomei MP, Nardi M, Martino E, Pinchera A 1998 Cigarette smoking and treatment outcomes in Graves ophthalmopathy. Ann Intern Med 129:632-635.
4. Karlsson F, Westermark K, Dahlberg PA, Jansson R, Enoksson P 1989 Ophthalmopathy and thyroid stimulation. Lancet 2:691.
5. Tallstedt L, Lundell G, Blomgren H, Bring J 1994 Does early administration of thyroxine reduce the development of Graves' ophthalmopathy after radioiodine treatment?. Eur J Endocrinol 130:494-497.
6. Shewan L, Coats A 2010 Ethics in the authorship and publishing of scientific articles. Int J Cardiol 144:1-2.
7. Tallstedt L, Lundell G, Torring O, Wallin G, Ljunggren JG, Blomgren H, Taube A 1992 Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism. The Thyroid Study Group. N Engl J Med 326:1733-1738.
8. Almqvist S, Algvere P 1972 Hypothyroidism in progressive ophthalmopathy of Graves' disease. Acta Ophthalmol (Copenh) 50:761-770.
9. Perros P, Kendall-Taylor P, Neoh C, Frewin S, Dickinson J 2005 A prospective study of the effects of radioiodine therapy for hyperthyroidism in patients with minimally active Graves' ophthalmopathy. J Clin Endocrinol Metab 90:5321-5323.
10. Hashizume K, Ichikawa K, Sakurai A, Suzuki S, Takeda T, Kobayashi M, Miyamoto T, Arai M, Nagasawa T 1991 Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism. [see comment]. N Engl J Med 324:947-953.
11. Bahn RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, Laurberg P, McDougall IR, Montori VM, Rivkees SA, Ross DS, Sosa JA, Stan MN 2010 Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid 20:593-646.
12. Bartalena L, Baldeschi L, Dickinson AJ, Eckstein A, Kendall-Taylor P, Marcocci C, Mourits MP, Perros P, Boboridis K, Boschi A, Curro N, Daumerie C, Kahaly GJ, Krassas G, Lane CM, Lazarus JH, Marino M, Nardi M, Neoh C, Orgiazzi J, Pearce S, Pinchera A, Pitz S, Salvi M, Sivelli P, Stahl M, von Arx G, Wiersinga WM 2008 Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy. Thyroid 18:333-346.
13. Stan MN, Bahn RS 2010 Risk factors for development or deterioration of Graves' ophthalmopathy. Thyroid 20:777-783.
14. Wellik M 2009 2008 Olmsted County Comunity Health Report Card. In: OCPH (ed) Services. OCPH, Rochester, MN, pp 1-16.
15. Lai A, Sassi L, Compri E, Marino F, Sivelli P, Piantanida E, Tanda ML, Bartalena L 2010 Lower dose prednisone prevents radioiodine-associated exacerbation of initially mild or absent graves' orbitopathy: a retrospective cohort study. J Clin Endocrinol Metab 95:1333-1337.
16. Perros P, Crombie AL, Kendall-Taylor P 1995 Natural history of thyroid associated ophthalmopathy. Clin Endocrinol (Oxf) 42:45-50.
17. Peduzzi P, Concato J, Feinstein AR, Holford TR 1995 Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. J Clin Epidemiol 48:1503-1510.